Indocyanine green as a new trend in sentinel lymphatic node detection in oncogynecology

Česká verze

Authors: Novák O.; Bartoš P.; Bučko R.
Authors place of work: Gynekologicko-porodnická klinika Nemocnice Nový Jičín AGEL a. s.
Published in the journal: Ceska Gynekol 2022; 87(1): 54-61
Category: Přehledový článek
doi: https://doi.org/10.48095/cccg202254

Summary

In oncological surgery the importance of the sentinel node concept is increasing, as we are capable of reducing the surgical burden of patients and its associated morbidity and preserving adequate oncological safety at the same time. Recently, there has been development of lymph node mapping techniques, where the most promising method appears to be the immunofluorescent one using indocyanine green dye. This technique provides high sensitivity in sentinel node detection in comparison with other existing methods using a dye in combination with a radionuclide. The indocyanine green technique has several advantages, and at the same time, we can use this method in non-oncological indications in gynecological surgery.

Keywords:

indocyanine green – oncogynecology – sentinel lymphatic node

Zdroje

1. Cibula D, Petružela L. Onkogynekologie. Praha: Grada 2009.

2. Morton DL, Wen DR, Wong JH et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127 (4): 392–399. doi: 10.1001/archsurg. 1992.01420040034005.

3. Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003; 349 (6): 546–553. doi: 10.1056/NEJMoa012782.

4. Levenback C, Burke TW, Morris M et al. Potential applications of intraoperative lymphatic mapping in vulvar cancer. Gynecol Oncol 1995; 59 (2): 216–220. doi: 10.1006/gyno.1995.0011.

5. Echt ML, Finan MA, Hoffman MS et al. Detection of sentinel lymph nodes with lymphazurin in cervical, uterine, and vulvar malignancies. South Med J 1999; 92 (2): 204–208. doi: 10.1097/00007611-199902000-00008.

6. Moncayo VM, Alazraki AL, Alazraki NP et al. Sentinel lymph node biopsy procedures. Semin Nucl Med 2017; 47 (6): 595–617. doi: 10.1053/j.semnuclmed.2017.06.004.

7. Nica A, Gien LT, Ferguson SE et al. Does small volume metastatic lymph node disease affect long-term prognosis in early cervical cancer? Int J Gynecol Cancer 2020; 30 (3): 285–290. doi: 10.1136/ijgc-2019-000928.

8. Van der Zee AG, Oonk MH, De Hullu JA et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol 2008; 26 (6): 884–889. doi: 10.1200/JCO.2007.14.0566.

9. Euscher ED, Malpica A, Atkinson EN et al. Ultrastaging improves detection of metastases in sentinel lymph nodes of uterine cervix squamous cell carcinoma. Am J Surg Pathol 2008; 32 (9): 1336–1343. doi: 10.1097/PAS.0b013e31816ec fe4.

10. Apple SK. Sentinel lymph node in breast cancer: review article from a pathologist’s point of view. J Pathol Transl Med 2016; 50 (2): 83–95. doi: 10.4132/jptm.2015.11.23.

11. ASTEC study group, Kitchener H, Swart AM et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study. Lancet 2009; 373 (9658): 125–136. doi: 10.1016/S0140-6736 (08) 61766-3.

12. de Boer M, van Deurzen CH, van Dijck JA et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009; 361 (7): 653–663. doi: 10.1056/NEJMoa0904832.

13. The sentinel node concept in cancers of the female genitalia. In: Schauer AJ, Becker W, Reiser M et al (eds). The sentinel lymph node concept. Berlin: Heidelberg, Springer 2005: 431–438. doi: 10.1007/3-540-26393-4_28.

14. Hassanzade M, Attaran M, Treglia G et al. Lymphatic mapping and sentinel node biopsy in squamous cell carcinoma of the vulva: systematic review and meta-analysis of the literature. Gynecol Oncol 2013; 130 (1): 237–245. doi: 10.1016/j.ygyno.2013.04.023.

15. Abu-Rustum NR, Angiolo R, Bailey AE et al. IGCS intraoperative technology taskforce. Update on near infrared imaging technology: beyond white light and the naked eye, indocyanine green and near infrared technology in the treatment of gynecologic cancers. Int J Gynecol Cancer 2020; 30 (5): 670–683. doi: 10.1136/ijgc-2019-001127.

16. Cwalinski T, Polom W, Marano L et al. Methylene blue-current knowledge, fluorescent properties, and its future use. J Clin Med 2020; 9 (11): 3538. doi: 10.3390/jcm9113538.

17. Polom K, Murawa D, Rho YS et al. Current trends and emerging future of indocyanine green usage in surgery and oncology: a literature review. Cancer 2011; 117 (21): 4812–4822. doi: 10.1002/cncr.26087.

18. Papadia A, Gasparri ML, Mueller MD. Are allergic reactions to indocyanine green really that uncommon? A single institution experiences. Obstet Gynecol Rep 2017; 1 (2): 1–2. doi: 10.15761/OGR.1000111.

19. Hutteman M, Mieog JS, van der Vorst JR et al. Randomized, double-blind comparison of indocyanine green with or without albumin premixing for near-infrared fluorescence imaging of sentinel lymph nodes in breast cancer patients. Breast Cancer Res Treat 2011; 127 (1): 163–170. doi: 10.1007/s10549-011-1419-0.

20. Egloff-Juras C, Bezdetnaya L, Dolivet G et al. NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green. Int J Nanomedicine 2019; 14: 7823–7838. doi: 10.2147/IJN.S207486.

21. SVOD analýza. 2022 [online]. Dostupné z: https: //www.svod.cz/analyse.php?modul= incmor#.

22. Mahner S, Jueckstock J, Hilpert F et al. Adjuvant therapy in lymph node-positive vulvar cancer: the AGO-CaRE-1 study. J Natl Cancer Inst 2015; 107 (3): dju426. doi: 10.1093/jnci/dju426.

23. Levenback CF, Ali S, Coleman RL et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. J Clin Oncol 2012; 30 (31): 3786–3791. doi: 10.1200/JCO.2011.41.2528.

24. Oonk MH, van Os MA, de Bock GH et al. A comparison of quality of life between vulvar cancer patients after sentinel lymph node procedure only and inguinofemoral lymphadenectomy. Gynecol Oncol 2009; 113 (3): 301–305. doi: 10.1016/j.ygyno.2008.12.006.

25. Rob L, Robova H, Pluta M et al. Further data on sentinel lymph node mapping in vulvar cancer by blue dye and radiocolloid Tc99. Int J Gynecolo Cancer 2007; 17 (1): 147–153. doi: 10.1111/j.1525-1438.2007.00806.x.

26. Soergel P, Hertel H, Nacke AK et al. Sentinel lymphadenectomy in vulvar cancer using near-infrared fluorescence from indocyanine green compared with technetium 99m nanocolloid. Int J Gynecol Cancer 2017; 27 (4): 805–812. doi: 10.1097/IGC.0000000000000996.

27. Schaafsma BE, Verbeek FP, Peters AA et al. Near-infrared fluorescence sentinel lymph node biopsy in vulvar cancer: a randomized comparison of lymphatic tracers. BJOG 2013; 120 (6): 758–764. doi: 10.1111/1471-0528.12173.

28. Institut de Cancérologie de Lorraine. Reliability of indocyanine green use in sentinel lymph node identification in cancer surgery. 2021 [online]. Available from: https: //clinicaltrials.gov/ct2/show/NCT02997553.

29. Scollo P. Indocyanine green fluorescence imaging, sentinel lymph node mapping in patients with vulvar cancer: peritumoral injection dosage and waiting times in our experience. 2020 [online]. Available from: https: //clinicaltrials.gov/ct2/show/NCT04663412.

30. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int J Clin Oncol 2007; 12 (3): 165–175. doi: 10.1007/s101 47-007-0661-2.

31. Benedetti Panici P, Basile S, Angioli R. Pelvic and aortic lymphadenectomy in cervical cancer: the standardization of surgical procedure and its clinical impact. Gynecol Oncol 2009; 113 (2): 284–290. doi: 10.1016/j.ygyno.2008.12.014.

32. Altgassen C, Hertel H, Brandstädt A et al. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008; 26 (18): 2943–2951. doi: 10.1200/JCO.2007.13.8933.

33. Mathevet P, Dorez M, Lecuru F et al. Sentinel lymph node biopsy for early cervical cancer: five years follow-up of a diagnostic, prospective, multicenter study (Senticol 1). Gynecol Oncolog 2017; 145 (Suppl 1): 92–93. doi: 10.1016/j.ygyno.2017.03.217.

34. Sláma J, Zikán M, Fischerová D et al. Přínos biopsie sentinelových uzlin pro léčbu lokálně pokročilých stadií karcinomu děložního hrdla. Ceska Gynekol 2016; 81 (3): 165–170.

35. Kocián R. Význam sentinelové uzliny u pacientek s časným karcinomem děložního hrdla. Ceska Gynekol 2020; 85 (): 344–351.

36. Frumovitz M, Plante M, Lee PS et al. Near-infrared fluorescence in the detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 2018; 19 (10): 1394–1403. doi: 10.1016/S1470-2045 (18) 30448-0.

37. Buda A, Papadia A, Di Martino G et al. Real-time fluorescent sentinel lymph node mapping with indocyanine green in women with previous conization undergoing laparoscopic surgery for early invasive cervical cancer: comparison with radiotracer ± blue dye. J Minim Invasive Gynecol 2018; 25 (3): 455–460. doi: 10.1016/j.jmig.2017.10.002.

38. Jewell EL, Huang JJ, Abu-Rustum NR et al. Detection of sentinel lymph nodes in minimally invasive surgery using indocyanine green and near-infrared fluorescence imaging for uterine and cervical malignancies. Gynecol Oncol 2014; 133 (2): 274–277. doi: 10.1016/j.ygyno.2014.02. 028.

39. Ramirez PT, Frumovitz M, Pareja R et al. Minimally invasive versus abdominal radical hysterectomy for cervical cancer. N Engl J Med 2018; 379 (20): 1895–1904. doi: 10.1056/ NEJMoa1806395.

40. Pelikan HM, Trum JW, Bakers FC et al. Diagnostic accuracy of preoperative tests for lymph node status in endometrial cancer: a systematic review. Cancer Imaging 2013; 13 (3): 314–322. doi: 10.1102/1470-7330.2013.0032.

41. Seamon LG, Fowler JM, Cohn DE. Lymphadenectomy for endometrial cancer: the controversy. Gynecol Oncol 2010; 117 (1): 6–8. doi: 10.1016/j.ygyno.2009.12.025.

42. Chi DS, Barakat RR, Palayekar MJ et al. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Int J Gynecol Cancer 2008; 18 (2): 269–273. doi: 10.1111/j.1525-1438.2007.00996.x.

43. Emons G, Vordermark D. Adjuvant treatment for endometrial cancer. Curr Opin Oncol 2019; 31 (5): 404–410. doi: 10.1097/CCO. 0000000000000558.

44. Frumovitz M, Plante M, Lee PS et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. Lancet Oncol 2018; 19 (10): 1394–1403. doi: 10.1016/S1470- 2045 (18) 30448-0.

45. Bodurtha Smith AJ, Fader AN, Tanner EJ. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta-analysis. Am J Obstet Gynecol 2017; 216 (5): 459.e10–476.e10. doi: 10.1016/j.ajog.2016.11.1033.

46. Geppert B, Lönnerfors C, Bollino M et al. A study on uterine lymphatic anatomy for standardization of pelvic sentinel lymph node detection in endometrial cancer. Gynecol Oncol 2017; 145 (2): 256–261. doi: 10.1016/j.ygyno.2017.02.018.

47. Rossi EC, Kowalski LD, Scalici J et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol 2017; 18 (3): 384–392. doi: 10.1016/S1470-2045 (17) 30068-2.

48. Persson J, Salehi S, Bollino M et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial) – the final step towards a paradigm shift in surgical staging. Eur J Cancer 2019; 116: 77–85. doi: 10.1016/j.ejca.2019.04.025.

49. Salehi S, Åvall-Lundqvist E, Legerstam B et al. Robot-assisted laparoscopy versus laparotomy for infrarenal paraaortic lymphadenectomy in women with high-risk endometrial cancer: a randomised controlled trial. Eur J Cancer 2017; 79: 81–89. doi: 10.1016/j.ejca.2017.03.038.

50. Kleppe M, Kraima AC, Kruitwagen RF et al. Understanding lymphatic drainage pathways of the ovaries to predict sites for sentinel nodes in ovarian cancer. Int J Gynecol Cancer 2015; 25 (8): 1405–1414. doi: 10.1097/IGC. 0000000000000514.

51. Lago V, Bello P, Montero B et al. Sentinel lymph node technique in early-stage ovarian cancer (SENTOV): a phase II clinical trial. Int J Gynecol Cancer 2020; 30 (9): 1390–1396. doi: 10.1136/ijgc-2020-001289.

52. Benedetti Panici P, Angioli R. Role of lymphadenectomy in ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2002; 16 (4): 529–551. doi: 10.1053/beog.2002.0301.

53. Querleu D, Planchamp F, Chiva L et al. European Society of Gynaecological Oncology (ESGO) guidelines for ovarian cancer surgery. Int J Gynecol Cancer 2017; 27 (7): 1534–1542. doi: 10.1097/IGC.0000000000001041.

54. Kimmig R, Buderath P, Rusch P et al. Early ovarian cancer surgery with indocyanine-green-guided targeted compartmental lymphadenectomy (TCL, pelvic part). J Gynecol Oncol 2017; 28 (5): e68. doi: 10.3802/jgo.2017.28.e68.

55. Blanco-Colino R, Espin-Basany E. Intraoperative use of ICG fluorescence imaging to reduce the risk of anastomotic leakage in colorectal surgery: a systematic review and meta-analysis. Tech Coloproctol 2018; 22 (1): 15–23. doi: 10.1007/s10151-017-1731-8.

56. Burnier P, Niddam J, Bosc R et al. Indocyanine green applications in plastic surgery: a review of the literature. J Plast Reconstr Aesthet Surg 2017; 70 (6): 814–827. doi: 10.1016/j.bjps.2017.01.020.

57. Ianieri MM, Della Corte L, Campolo F et al. Indocyanine green in the surgical management of endometriosis: a systematic review. Acta Obstet Gynecol Scand 2021; 100 (2): 189–199. doi: 10.1111/aogs.13971.

58. Jayakumaran J, Pavlovic Z, Fuhrich D et al. Robotic single-site endometriosis resection using near-infrared fluorescence imaging with indocyanine green: a prospective case series and review of literature. J Robot Surg 2020; 14 (1): 145–154. doi: 10.1007/s11701-019-00 951-0.